ReviewProceedings of the National Academy of Sciences of the United States of America2014

Unleashing the potential of NOD- and Toll-like agonists as vaccine adjuvants.

Charles Maisonneuve et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.